Investeerders voor farma start-up
Identifying strategic partners/investors for the potential blockbuster medicine of an innovative bioscience company
Our client is a is an innovative bioscience company based in the Netherlands. The mission of the company involves the development of innovative products based on artificial intelligence for an individualized approach in medicine, drug development and health care. The company develops various activities and initiatives.
The company has developed two new medicines for Hypoactive Sexual Desire Disorder (HSDD). Low sexual desire, with or without sexual arousal problems, is the most common sex-related complaint reported by women. This condition is widespread and is considered by many as an unmet medical need. The two new medicines are believed to have blockbuster potential. The company would like to attract investors and strategic partners for further clinical development and commercialization of these products.
Potential investors were found as a result
We developed and executed a strategy to attract potential investors and strategic partners in the EU, USA, China and India.